Published in Acta Neurol Scand on December 01, 2007
The role of oxidative stress in Parkinson's disease. J Parkinsons Dis (2013) 1.86
Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol Disord Drug Targets (2009) 1.30
Inflammation and adaptive immunity in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.22
Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev Med Chem (2009) 1.03
Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants. PLoS One (2010) 0.96
The endotoxin-induced neuroinflammation model of Parkinson's disease. Parkinsons Dis (2011) 0.89
Evidence of inflammatory system involvement in Parkinson's disease. Biomed Res Int (2014) 0.89
Pathways towards an effective immunotherapy for Parkinson's disease. Expert Rev Neurother (2011) 0.84
HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways. PLoS One (2013) 0.83
Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance? Hum Vaccin Immunother (2014) 0.82
Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease. Parkinsons Dis (2014) 0.82
Correlation between serum RANTES levels and the severity of Parkinson's disease. Oxid Med Cell Longev (2014) 0.79
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies. Int J Mol Sci (2016) 0.78
NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases. J Amino Acids (2011) 0.77
Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice. Mol Neurodegener (2017) 0.75
A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson's Disease in Isparta, Turkey. Parkinsons Dis (2016) 0.75
Immune-mediated processes in neurodegeneration: where do we stand? J Neurol (2016) 0.75
Hepatitis B e antigen-negative chronic hepatitis B. Hepatology (2001) 2.29
Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? Acta Neurol Scand (2010) 1.69
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Paraneoplastic limbic encephalitis presenting as acute viral encephalitis. J Neurooncol (2005) 1.54
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis (2006) 1.48
Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha. Clin Immunol Immunopathol (1996) 1.46
Angelman syndrome with uniparental disomy due to paternal meiosis II nondisjunction. Clin Genet (1999) 1.44
Neuropathy following acute intoxication with Mecarbam (OP ester) Acta Neurol Scand (1991) 1.42
Mutational analysis of PMP22, GJB1 and MPZ in Greek Charcot-Marie-Tooth type 1 neuropathy patients. Clin Genet (2011) 1.41
Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease. Eur J Neurol (2007) 1.30
Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European Prospective Investigation into Cancer and Nutrition). Public Health Nutr (2008) 1.21
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis (2004) 1.20
Incidence and clinical presentation of neurosyphilis: a retrospective study of 81 cases. Int J Neurosci (2008) 1.17
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord (2007) 1.07
IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci (2005) 1.04
Melkersson-Rosenthal's syndrome in four generations. Clin Genet (1979) 1.03
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature. Case Rep Neurol Med (2013) 1.00
Factors influencing acute blood pressure values in stroke subtypes. J Hum Hypertens (2004) 0.98
Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet (1999) 0.97
Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease? J Neurol Neurosurg Psychiatry (2001) 0.97
Circulating interleukin-10 and interleukin-12 in Parkinson's disease. Acta Neurol Scand (2008) 0.96
Nucleo-cytoplasmic ratio in ageing skeletal muscle. Eur Arch Psychiatry Neurol Sci (1987) 0.96
Karyometric changes in human muscle with age. Eur Neurol (1977) 0.95
Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob Agents Chemother (2005) 0.95
Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations. J Neurol Neurosurg Psychiatry (1998) 0.94
Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg (2005) 0.93
CSF biomarker profile and diagnostic value in vascular dementia. Eur J Neurol (2009) 0.93
Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study. Mult Scler (2008) 0.92
CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol (2003) 0.92
Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand (2007) 0.92
Frontal lobe dysfunction in amyotrophic lateral sclerosis. J Neurol Sci (2002) 0.92
The role of soluble intercellular adhesion molecules in neurodegenerative disorders. J Neurol Sci (2004) 0.91
Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene. Neurology (2001) 0.91
Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurol Scand (1997) 0.91
Apolipoprotein E allele distribution in parents of Down's syndrome children. Lancet (1996) 0.89
A normative study of the trail making test A and B in Greek adults. Clin Neuropsychol (2007) 0.88
Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest (1992) 0.88
Early recovery of oxygen kinetics after submaximal exercise test predicts functional capacity in patients with chronic heart failure. Eur J Heart Fail (2001) 0.87
Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis. Clin Microbiol Infect (2001) 0.87
Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population. J Clin Neurosci (2007) 0.87
Apolipoprotein E and presenilin-1 genotypes in Huntington's disease. J Neurol (1999) 0.87
Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res (2001) 0.87
Vertical and horizontal integrator failure in a ponto-medullary infarction: A possible role for paramedian tract neurons. J Neurol Sci (2009) 0.87
Huntington's disease in Greece: the experience of 14 years. Clin Genet (2010) 0.86
Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood (1998) 0.86
Churg-Strauss syndrome complicated by neuropathy: a clinicopathological study of nine cases. Clin Neuropathol (2010) 0.86
Spinal muscular atrophy, Dandy-Walker complex, and cataracts in two siblings: a new entity? J Neurol Neurosurg Psychiatry (2005) 0.86
Partial trisomy 17q22-qter and partial monosomy Xq27-qter in a girl with a de novo unbalanced translocation due to a postzygotic error: case report and review of the literature on partial trisomy 17qter. Am J Med Genet (1997) 0.86
Time-frequency analysis methods to quantify the time-varying microstructure of sleep EEG spindles: possibility for dementia biomarkers? J Neurosci Methods (2009) 0.86
Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two generations. J Neurol (2004) 0.86
Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment. Neurology (2002) 0.85
A simple and effective approach for detecting maternal cell contamination in molecular prenatal diagnosis. Prenat Diagn (2002) 0.85
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis. Mult Scler (2008) 0.84
APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology (2007) 0.84
Hereditary neuropathy with liability to pressure palsies: the same molecular defect can result in diverse clinical presentation. J Neurol (1996) 0.84
Gadopentetate dimeglumine-enhanced MR in the diagnosis of the Tolosa-Hunt syndrome. AJNR Am J Neuroradiol (1995) 0.84
Increased cerebrospinal fluid tau protein in multiple sclerosis. Eur Neurol (2000) 0.83
Polyneuropathies in the elderly: a clinico pathological study of 74 cases. Int J Neurosci (2006) 0.83
Dietary lipids and geriatric depression scale score among elders: the EPIC-Greece cohort. J Psychiatr Res (2008) 0.82
IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. J Geriatr Psychiatry Neurol (2006) 0.82
Electrophysiological study (EEG, VEPs, BAEPs) in patients with Charcot Marie Tooth (type HMSN I) disease. Electromyogr Clin Neurophysiol (1989) 0.82
Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease. J Geriatr Psychiatry Neurol (2004) 0.82
The role of IL-15 in central nervous system disorders. Acta Neurol Scand (2011) 0.82
Immune cell biochemical abnormalities in systemic lupus erythematosus. Clin Exp Rheumatol (1998) 0.81
Muscle nuclear size in neuromuscular disease. J Neurol Neurosurg Psychiatry (1976) 0.81